Prognostic implications of netrin-1 expression and its receptors in patients with adenocarcinoma of the pancreas.

Standard

Prognostic implications of netrin-1 expression and its receptors in patients with adenocarcinoma of the pancreas. / Link, Björn-Chr.; Reichelt, Uta; Schreiber, Matthias; Kaifi, Jussuf; Wachowiak, Robin; Bogoevski, Dean; Bubenheim, Michael; Cataldegirmen, Güllü; Gawad, Karim A.; Issa, Rana; Koops, Susan; Izbicki, Jakob R.; Yekebas, Emre F.

In: ANN SURG ONCOL, Vol. 14, No. 9, 9, 2007, p. 2591-2599.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Link, B-C, Reichelt, U, Schreiber, M, Kaifi, J, Wachowiak, R, Bogoevski, D, Bubenheim, M, Cataldegirmen, G, Gawad, KA, Issa, R, Koops, S, Izbicki, JR & Yekebas, EF 2007, 'Prognostic implications of netrin-1 expression and its receptors in patients with adenocarcinoma of the pancreas.', ANN SURG ONCOL, vol. 14, no. 9, 9, pp. 2591-2599. <http://www.ncbi.nlm.nih.gov/pubmed/17549567?dopt=Citation>

APA

Link, B-C., Reichelt, U., Schreiber, M., Kaifi, J., Wachowiak, R., Bogoevski, D., Bubenheim, M., Cataldegirmen, G., Gawad, K. A., Issa, R., Koops, S., Izbicki, J. R., & Yekebas, E. F. (2007). Prognostic implications of netrin-1 expression and its receptors in patients with adenocarcinoma of the pancreas. ANN SURG ONCOL, 14(9), 2591-2599. [9]. http://www.ncbi.nlm.nih.gov/pubmed/17549567?dopt=Citation

Vancouver

Link B-C, Reichelt U, Schreiber M, Kaifi J, Wachowiak R, Bogoevski D et al. Prognostic implications of netrin-1 expression and its receptors in patients with adenocarcinoma of the pancreas. ANN SURG ONCOL. 2007;14(9):2591-2599. 9.

Bibtex

@article{d801ef461fba4951a2fd3cca969c8a5c,
title = "Prognostic implications of netrin-1 expression and its receptors in patients with adenocarcinoma of the pancreas.",
abstract = "BACKGROUND: To assess the interaction between the expression of netrin-1 or of its receptors to the prognosis of ductal adenocarcinoma of the pancreas. METHODS: In 82 patients with resectable pancreatic adenocarcinoma who underwent curative operation, the expression patterns of netrin-1, deleted in colorectal carcinomas (DCC), UNC5H3, and neogenin were determined by immunohistochemical staining. Kaplan-Meier analysis was performed to assess the prognostic relevance of the examined expression patterns. RESULTS: Median follow-up was 15 +/- 19.9 months (range, 4-108 months). Patients suffering from tumors with no or little expression of netrin-1 (n = 67) had a median recurrence-free survival of 10 months (95% CI, 7-13 months), while a middle to strong expression (n = 15) was associated with a significantly worse median recurrence-free survival of only four months (95% CI, three to five months, p = 0.0165). Overall and recurrence-free survival showed no significant differences between the different expression patterns of DCC, UNC5H3 or neogenin. Netrin-1 expression had significant impact (p = 0.001) on overall survival of patients suffering from poorly differentiated tumors. Stratification according to the nodal status revealed significant influence (p = 0.007) of UNC5H3 expression on the overall survival of patients with pN1 status. CONCLUSION: Expression of netrin-1 has significant impact on time to tumor relapse in adenocarcinoma of the pancreas. Netrin-1 expression is associated with worse outcome in poorly differentiated pancreatic adenocarcinomas. Risk-stratification according to the UNC5H3 receptor expression pattern shows that node positive patients (pN1) with no to little UNC5H3 expression carry a significantly worse prognosis than those with middle to strong UNC5H3 expression.",
author = "Bj{\"o}rn-Chr. Link and Uta Reichelt and Matthias Schreiber and Jussuf Kaifi and Robin Wachowiak and Dean Bogoevski and Michael Bubenheim and G{\"u}ll{\"u} Cataldegirmen and Gawad, {Karim A.} and Rana Issa and Susan Koops and Izbicki, {Jakob R.} and Yekebas, {Emre F.}",
year = "2007",
language = "Deutsch",
volume = "14",
pages = "2591--2599",
journal = "ANN SURG ONCOL",
issn = "1068-9265",
publisher = "Springer New York",
number = "9",

}

RIS

TY - JOUR

T1 - Prognostic implications of netrin-1 expression and its receptors in patients with adenocarcinoma of the pancreas.

AU - Link, Björn-Chr.

AU - Reichelt, Uta

AU - Schreiber, Matthias

AU - Kaifi, Jussuf

AU - Wachowiak, Robin

AU - Bogoevski, Dean

AU - Bubenheim, Michael

AU - Cataldegirmen, Güllü

AU - Gawad, Karim A.

AU - Issa, Rana

AU - Koops, Susan

AU - Izbicki, Jakob R.

AU - Yekebas, Emre F.

PY - 2007

Y1 - 2007

N2 - BACKGROUND: To assess the interaction between the expression of netrin-1 or of its receptors to the prognosis of ductal adenocarcinoma of the pancreas. METHODS: In 82 patients with resectable pancreatic adenocarcinoma who underwent curative operation, the expression patterns of netrin-1, deleted in colorectal carcinomas (DCC), UNC5H3, and neogenin were determined by immunohistochemical staining. Kaplan-Meier analysis was performed to assess the prognostic relevance of the examined expression patterns. RESULTS: Median follow-up was 15 +/- 19.9 months (range, 4-108 months). Patients suffering from tumors with no or little expression of netrin-1 (n = 67) had a median recurrence-free survival of 10 months (95% CI, 7-13 months), while a middle to strong expression (n = 15) was associated with a significantly worse median recurrence-free survival of only four months (95% CI, three to five months, p = 0.0165). Overall and recurrence-free survival showed no significant differences between the different expression patterns of DCC, UNC5H3 or neogenin. Netrin-1 expression had significant impact (p = 0.001) on overall survival of patients suffering from poorly differentiated tumors. Stratification according to the nodal status revealed significant influence (p = 0.007) of UNC5H3 expression on the overall survival of patients with pN1 status. CONCLUSION: Expression of netrin-1 has significant impact on time to tumor relapse in adenocarcinoma of the pancreas. Netrin-1 expression is associated with worse outcome in poorly differentiated pancreatic adenocarcinomas. Risk-stratification according to the UNC5H3 receptor expression pattern shows that node positive patients (pN1) with no to little UNC5H3 expression carry a significantly worse prognosis than those with middle to strong UNC5H3 expression.

AB - BACKGROUND: To assess the interaction between the expression of netrin-1 or of its receptors to the prognosis of ductal adenocarcinoma of the pancreas. METHODS: In 82 patients with resectable pancreatic adenocarcinoma who underwent curative operation, the expression patterns of netrin-1, deleted in colorectal carcinomas (DCC), UNC5H3, and neogenin were determined by immunohistochemical staining. Kaplan-Meier analysis was performed to assess the prognostic relevance of the examined expression patterns. RESULTS: Median follow-up was 15 +/- 19.9 months (range, 4-108 months). Patients suffering from tumors with no or little expression of netrin-1 (n = 67) had a median recurrence-free survival of 10 months (95% CI, 7-13 months), while a middle to strong expression (n = 15) was associated with a significantly worse median recurrence-free survival of only four months (95% CI, three to five months, p = 0.0165). Overall and recurrence-free survival showed no significant differences between the different expression patterns of DCC, UNC5H3 or neogenin. Netrin-1 expression had significant impact (p = 0.001) on overall survival of patients suffering from poorly differentiated tumors. Stratification according to the nodal status revealed significant influence (p = 0.007) of UNC5H3 expression on the overall survival of patients with pN1 status. CONCLUSION: Expression of netrin-1 has significant impact on time to tumor relapse in adenocarcinoma of the pancreas. Netrin-1 expression is associated with worse outcome in poorly differentiated pancreatic adenocarcinomas. Risk-stratification according to the UNC5H3 receptor expression pattern shows that node positive patients (pN1) with no to little UNC5H3 expression carry a significantly worse prognosis than those with middle to strong UNC5H3 expression.

M3 - SCORING: Zeitschriftenaufsatz

VL - 14

SP - 2591

EP - 2599

JO - ANN SURG ONCOL

JF - ANN SURG ONCOL

SN - 1068-9265

IS - 9

M1 - 9

ER -